Antimicrobial Resistance in India: Why Antibiotic Overuse Is Not the Only Problem

Antimicrobial Resistance in India Newest Information

• A brand new examine by the Indian Council of Medical Analysis (ICMR) has discovered that infections attributable to antibiotic-resistant Gram-negative micro organism are deadlier and costlier to deal with than infections attributable to drug-susceptible strains. 
• India’s antimicrobial resistance (AMR) disaster goes effectively past antibiotic overuse. Delayed prognosis, hospital transmission and weak an infection management are equally accountable.

Understanding Gram-Destructive Micro organism and Carbapenems

• Gram-negative micro organism have a skinny peptidoglycan cell wall and an outer membrane containing lipopolysaccharides. They stain pink or purple throughout Gram staining.
• They trigger infections within the lungs, urinary tract, wounds and bloodstream. Widespread hospital pathogens on this group embody Escherichia coli (E. coli), Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa.
• Carbapenems are a robust class of antibiotics used for severe infections. They’re usually the final line of defence. 
• When micro organism turn out to be proof against carbapenems, medical doctors are left with only a few efficient medicines.

Key Findings of the ICMR Research

• The examine was performed by ICMR’s antimicrobial resistance surveillance community throughout 20 tertiary-care hospitals between April 2022 and April 2025. 
• Mortality was persistently greater amongst sufferers with carbapenem-resistant infections throughout all 4 main pathogens. The relative threat of dying was 1.16 to 1.43 occasions greater. 
• Greater than 61 per cent of Gram-negative infections within the examine have been carbapenem-resistant. 
• Specialists name carbapenem resistance a serious menace to affected person survival, particularly in extreme and bloodstream infections. Nonetheless, they warning towards treating resistance as a completely impartial explanation for dying. 
• Severity of sickness, timing of remedy, supply management and affected person elements additionally form outcomes. Resistance is finest understood as an necessary marker of extra mortality.
• The examine additionally factors to healthcare-associated transmission, invasive units, latest surgical procedure, antibiotic stress and gaps in an infection prevention and prognosis. 
• AMR is the product of a posh interplay amongst these elements. It can’t be lowered to antibiotic overuse alone.

The Hidden Financial Burden

• The examine’s value figures are conservative. Researchers regarded solely at the price of antibiotics out there beneath the Jan Aushadhi scheme. 
• They excluded ICU fees, mattress prices, diagnostics, procedures, supportive care and session charges.
• Even on this slender measure, antibiotic prices for resistant infections have been 1.1 to 2 occasions greater. The true burden on sufferers, households and the healthcare system is probably going far larger.

A Sign, Not a Verdict, on Newer Medicine

• The antibiotic Ceftazidime-avibactam was linked to raised outcomes in some resistant E. coli and Ok. pneumoniae infections, together with bloodstream infections. Specialists describe this as an necessary sign slightly than proof of superiority. 
• The examine was observational and couldn’t absolutely regulate for illness severity, timing of remedy or resistance mechanisms. 
• The outcomes replicate real-world remedy patterns in India, not a definitive drug rating. 
• This underlines the necessity for higher diagnostics to information remedy as a substitute of merely escalating to newer, broader antibiotics.

Antibiotics Can’t Exchange An infection Prevention

• Greater than 85 per cent of bloodstream infections within the examine have been healthcare-associated. This reveals that Indian hospitals are counting on antibiotics to repair what is actually an infection-prevention failure.
• Hospitals should place an infection prevention and management on the centre of their AMR response. 
• This contains hand hygiene, prevention of device-associated infections, acceptable insertion and early removing of invasive units, environmental cleansing, surgical an infection prevention and surveillance of healthcare-associated infections.
• Antimicrobial stewardship is equally important. The reply to rising resistance shouldn’t be stronger antibiotics. 
• It’s to forestall infections, diagnose them rapidly and use the narrowest efficient antibiotic for the shortest acceptable period.

The Means Ahead: An Built-in Response

• First, India should transfer from isolate-based surveillance to built-in surveillance that hyperlinks laboratory outcomes with affected person outcomes, mortality and remedy. 
• Second, sooner and extra correct diagnostics are wanted to tell apart bacterial from non-bacterial sickness and detect resistance early. 
• Third, antimicrobial stewardship should turn out to be routine medical apply, not an elective programme. 
• Fourth, an infection prevention should obtain as a lot consideration as prescribing. 
• Lastly, India wants accountable entry to newer antimicrobials, backed by stewardship, so these medication stay efficient when actually wanted.

Conclusion

• The ICMR examine confirms that carbapenem resistance is a severe menace to survival and a heavy financial burden. India’s AMR disaster can’t be solved by discovering a brand new antibiotic every time an previous one fails. 
• Stopping infections, diagnosing them early and preserving present antibiotics should turn out to be the core of nationwide well being coverage.

Supply: IE